Seroprevalence of HDV Infection among HBsAg Positive Blood Donor in Baqubah City, Iraq

Seroprevalence of HDV Infection among HBsAg Positive Blood Donor in Baqubah City, Iraq

Show other versions (1)

Background: Hepatitis B virus (HBV) is the most important causative agent of blood borne hepatitis in humans. Hepatitis D Virus (HDV) infection occurs either as a co-infection or super infection in HBV carriers. Objective:To determine the seroprevalence of HDV among blood donors (HBsAg positive...

Full description

Bibliographic Details
Main Authors:	Linda Munjed Hadi, Areej Atiyah Hussein, Ali Musa Ja'afer
Format:	Article
Language:	English
Published:	College of medicine/ University of Diyala 2018-09-01
Series:	Diyala Journal of Medicine
Subjects:	Hepatitis, HBV, HDV, Blood donor
Online Access:	https://www.djm.uodiyala.edu.iq/index.php/djm/article/view/119

Similar Items

Seroprevalence of HDV Infection among HBsAg Positive Blood Donor in Baqubah City, Iraq
by: Linda Munjed Hadi, et al.
Published: (2018-09-01)

The prevalence of HDV among HBsAg-positive populations with and without HIV-1 in China
by: Yan Wang, et al.
Published: (2024-03-01)

Seroprevalence of HDV among non-hospitalized HBsAg positive patients from KPK-region of Pakistan
by: Ismail Jalil, et al.
Published: (2016-07-01)

Anti-HDV seroprevalance among patients with previous HBV infection
by: Abdurrahman Sahin, et al.
Published: (2018-06-01)

Implementation of anti-HDV reflex testing among HBsAg-positive individuals increases testing for hepatitis D
by: Adriana Palom, et al.
Published: (2022-10-01)

Seroprevalence of HBsAg, Anti-HBs, anti-HDV and HDVAg in Inonu University Medical Faculty Hospital, 2012 [Inonu Universitesi Tip Fakultesi Hastanesinde, 2012 Yilinda, HBsAg, Anti-HBs, Anti-HDV ve HDVAg Seroprevalansi]
by: Yucel Duman, et al.
Published: (2014-03-01)

Phylogenetic analysis of HDV isolates from HBsAg positive patients in Karachi, Pakistan
by: Perveen Shadab, et al.
Published: (2012-08-01)

HDV Can Constrain HBV Genetic Evolution in HBsAg: Implications for the Identification of Innovative Pharmacological Targets
by: Luna Colagrossi, et al.
Published: (2018-07-01)

Pre-transplant donor HBV DNA+ and male recipient are independent risk factors for treatment failure in HBsAg+ donors to HBsAg- kidney transplant recipients
by: Xian-ding Wang, et al.
Published: (2021-01-01)

The Role of Antiviral Prophylaxis in Preventing HBV and HDV Recurrence in the Setting of Liver Transplantation
by: Sara Battistella, et al.
Published: (2023-04-01)

The prevalence of Co-infection with HCV and HDV in HBV infected patients in Golestan province of Iran
by: Gholamreza Roshandel, et al.
Published: (2008-01-01)

Serological characteristics of HBsAg positive/HBV DNA non-reactive blood donors
by: Yuanyuan JING, et al.
Published: (2024-04-01)

Effect of S-region mutations on HBsAg in HBsAg-negative HBV-infected patients
by: Hui Liu, et al.
Published: (2024-04-01)

Early Multiphasic HBV Infection Initiation Kinetics Is Not Clone-Specific and Is Not Affected by Hepatitis D Virus (HDV) Infection
by: Masataka Tsuge, et al.
Published: (2019-03-01)

Evolutionary trends in the prevalence of anti-HDV antibodies among patients positive for HBsAg referred to a national laboratory in Cameroon from 2012 to 2017
by: Laurence Noubissi-Jouegouo, et al.
Published: (2019-07-01)

HDV Pathogenesis: Unravelling Ariadne’s Thread
by: Eirini D. Tseligka, et al.
Published: (2021-04-01)

A Mathematical Model for Early HBV and -HDV Kinetics during Anti-HDV Treatment
by: Rami Zakh, et al.
Published: (2021-12-01)

Characteristics of HBcrAg in HBsAg-/HBV DNA+ blood donors in Wuxi area
by: Yan WANG, et al.
Published: (2024-01-01)

Prevalence of anti HDV in HBV carriers in Babol during 2000-02
by: MR Hassanjani Roshan, et al.
Published: (2004-01-01)

Low prevalence of hepatitis delta infection in Cuban HBsAg carriers: Prospect for elimination
by: Licel de los Ángeles Rodríguez Lay, et al.
Published: (2023-02-01)

HBsAg non-reactive but HBV DNA reactive blood donors in Wuhu area: infection status and tracing results
by: Jie WU, et al.
Published: (2023-01-01)

Discontinuation of Passive Immunization Is Safe after Liver Transplantation for Combined HBV/HDV Infection
by: Ramin Raul Ossami Saidy, et al.
Published: (2021-05-01)

Identification of Novel HBV/HDV Entry Inhibitors by Pharmacophore- and QSAR-Guided Virtual Screening
by: Michael Kirstgen, et al.
Published: (2021-07-01)

Circulation of HDV Genotypes in Brazil: Identification of a Putative Novel HDV-8 Subgenotype
by: Francisco C. A. Mello, et al.
Published: (2023-06-01)

Prevalence and risk factors for HBV, HCV and HDV infections among injecting drug users from Rio de Janeiro, Brazil
by: M.L.A. Oliveira, et al.
Published: (1999-09-01)

High rates of cirrhosis and severe clinical events in patients with HBV/HDV co-infection: longitudinal analysis of a German cohort
by: Jan-Hendrik Bockmann, et al.
Published: (2020-01-01)

Key Factors for “Fishing” NTCP as a Functional Receptor for HBV and HDV
by: Huan Yan, et al.
Published: (2023-02-01)

Successful treatment of HCV/HBV/HDV-coinfection with pegylated interferon and ribavirin
by: Janine Hartl, et al.
Published: (2012-07-01)

IL-10 Promoter Polymorphism Distribution among HBsAg-Reactive and HBsAg-Nonreactive Blood Donors
by: Rahmat Azhari Kemal, et al.
Published: (2020-03-01)

Investigation of HBV DNA in HBsAg positive patients
by: Nihal Secil Bati, et al.
Published: (2017-12-01)

RESULTS OF GENOTYPING HEPATITIS VIRUS B IN HBsAg-NEGATIVE BLOOD DONORS IN ASTANA, KAZAKHSTAN
by: Yu. V. Ostankova, et al.
Published: (2018-01-01)

Rates of HBV, HCV, HDV and HIV type 1 among pregnant women and HIV type 1 drug resistance-associated mutations in breastfeeding women on antiretroviral therapy
by: Judith N. Torimiro, et al.
Published: (2018-12-01)

IFITM3 Interacts with the HBV/HDV Receptor NTCP and Modulates Virus Entry and Infection
by: Massimo Palatini, et al.
Published: (2022-03-01)

A Hyper-Glycosylation of HBV Surface Antigen Correlates with HBsAg-Negativity at Immunosuppression-Driven HBV Reactivation in Vivo and Hinders HBsAg Recognition In Vitro
by: Romina Salpini, et al.
Published: (2020-02-01)

Seroprevalence of hepatitis B, C and D viral among hemodialysis patients in Tehran
by: Davood Yadegarynia, et al.
Published: (2017-10-01)

Highly Sensitive HBsAg, Anti-HBc and Anti HBsAg Titres in Early Diagnosis of HBV Reactivation in Anti-HBc-Positive Onco-Haematological Patients
by: Carlotta Cerva, et al.
Published: (2022-02-01)

HepG2BD: A Novel and Versatile Cell Line with Inducible HDV Replication and Constitutive HBV Expression
by: Matthieu Blanchet, et al.
Published: (2024-03-01)

Comparing methods for plasma HDV RNA quantification in bulevirtide-treated and untreated patients with HDV
by: Maria Paola Anolli, et al.
Published: (2025-03-01)

Seronegativity HBsAg, HCV and HIV among blood donors: A five year study
by: Om Bodarya, et al.
Published: (2015-01-01)

Hepatitis B reactivation characterized by HBsAg negativity and anti-HbsAg antibodies persistence in haematopoietic stem cell transplanted patient after lamivudine withdrawal
by: C. Cerva, et al.
Published: (2017-08-01)